
Vefax 37.5mg Tablet XR
Marketer
Micron Biotech
Salt Composition
Venlafaxine (37.5mg)
Overview Vefax 37.5mg Tablet XR
Axilon 37.5mg Extended-Release Tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, edginess, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Axilon 37.5mg Extended-Release Tablets should be taken with food, at the same time daily for consistent blood levels. Missed doses should be taken promptly; do not skip doses and complete the prescribed course, even if feeling improved. Abrupt cessation may worsen symptoms. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, anxiety, constipation, increased sweating, and sexual problems. Dizziness and drowsiness may occur; avoid driving or tasks requiring alertness until effects are known. These side effects are usually transient. Persistent or bothersome side effects require medical attention. Prior to using Axilon 37.5mg Extended-Release Tablets, disclose any kidney, heart, or liver conditions, or seizure history to your physician. Report any unusual mood or behavior changes, worsening depression, or suicidal thoughts immediately.
Uses of Vefax 37.5mg Tablet XR
Mood disorders encompassing sadness and worry
Major Benefits of Vefax 37.5mg Tablet XR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vefax 37.5mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Vefax 37.5mg Tablet XR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Vefax 37.5mg Tablet XR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vefax 37.5mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Vefax 37.5mg Tablet XR works:
Extended-release Vefax 37.5mg tablets function by elevating brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vefax 37.5mg Tablet XR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vefax 37.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vefax 37.5mg tablets are likely unsafe for breastfeeding mothers. Studies in humans indicate potential transfer to breast milk, posing a risk to the infant. Close monitoring of infants for drowsiness and appropriate weight increase is recommended.
DrivingUNSAFE
Driving ability may be impaired by Vefax 37.5mg XR tablets, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.
KidneyCAUTION
Extended-release Vefax 37.5mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Vefax 37.5mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Vefax 37.5mg extended-release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vefax 37.5mg Tablet XR :
Should you forget a Vefax 37.5mg extended-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Vefax 37.5mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Anisole-based Compound |
| Developing Habits | No. |
| Type of Therapy | Neuroscience and Central Nervous System |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
